Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | ZE46-0134 |
Synonyms | |
Therapy Description |
Limited information is currently available on ZE46-0134, a putative pan-FLT3/IRAK4 inhibitor (Apr 2024). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
ZE46-0134 | lomonitinib | FLT3 Inhibitor 69 IRAK4 Inhibitor 7 | Limited information is currently available on ZE46-0134, a putative pan-FLT3/IRAK4 inhibitor (Apr 2024). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT06366789 | Phase I | ZE46-0134 | Dose Escalation and Expansion Study to Evaluate the Safety, PK, PD and Efficacy of ZE46-0134 in Adults With FLT3 Mutated Relapsed or Refractory Acute Myeloid Leukemia | Not yet recruiting | AUS | 0 |